IQ Capital’s Post

How can the new Dimensions Biotech Solution enable companies to be one step ahead in the rapidly evolving domains of #LifeSciences and #biotech? 🦠🧫🔬🧬💊 From #omics, to next-gen sequencing, and what to do with all that research data... find out more in this new blog post from Misha Kidambi. Discover how Dimensions can meet our customers' complex needs: https://ow.ly/6HWr50QuHhw

Metagenomic Sequencing Market worth $4.5 billion in 2028 Download PDF Brochure:-https://lnkd.in/dSFMPUz5 The global metagenomic sequencing market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $4.5 billion in 2028, growing at a CAGR of 17.5% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, (US), Thermo Fisher Scientific (US), QIAGEN(Netherlands), PerkinElmer, (US), and Oxford Nanopore Technologies (UK) 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 PACIFIC BIOSCIENCES OF CALIF Bio-Rad Laboratories, Agilent Technologies, Illumina Ventures BGI Genomics GeneWize Zymo Research Corp. Novogene Takara Bio Inc. Twist Bioscience 10x Genomics Integrated DNA Technologies Promega Corporation GATC BIOTECH SARL Strand Life Sciences Eurofins Genomics Biomatters2u Sage Science, Inc. Microsynth AG Daicel Arbor Biosciences DNAnexus BaseClear Molzym GmbH & Co. KG Macrogen Inc. Singlera Genomics Incorporated Lexogen LC Sciences Tecan Roche NimbleGen Inc. Lucigen Corp. Anatrace HudsonAlpha Institute for Biotechnology Bioneer Corporation Stilla Technologies Metabiomics. #metagenomics #nextgensequencing #microbiome #genomicsresearch #bioinformatics

Dive into our webinar: “In-Vitro and In-Silico Screening for Antiviral Natural Compounds” in our series on “Importance of Natural Products in Therapeutics and Drug Discovery”. 📆 Date: 30th May ⏰ Time: 11:00 AM 📝 Register Now: https://lnkd.in/gU4WHfMd Dr. Anbu Kumar will discuss the therapeutic potential of natural compounds, which have been used since prehistoric times. Modern technologies and bioinformatics tools enhance our ability to identify these compounds by examining protein and biomolecule interactions at molecular and cellular levels. The combination of in vitro and in silico methods is key to uncovering valuable therapeutic compounds from natural sources. #NaturalMedicine #Bioinformatics #TherapeuticCompounds #Biotechnology #InSilicoTools Dassault Systèmes BIOVIA

Transformative Use Cases of Artificial Intelligence AI Across Biotechnology AI is a pivotal tool for biotechnology, offering transformative solutions to many challenges. From drug discovery and safety to genomics, proteomics, and pharmacology, AI’s applications span a broad spectrum within the field. The effective utilizati... https://lnkd.in/eUCHTHSc #AI #ML #Automation

Genomics Market worth $83.1 billion by 2028 Download PDF Brochure:-https://lnkd.in/dHYDr43x The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐬 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer. Wohlfahrtsstiftung der F. Hoffmann-La Roche AG 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 BGI Genomics Oxford Nanopore Technologies PacBio 10x Genomics Bio-Rad Laboratories, Genomatix Software GmbH Twist Bioscience Macrogen Inc. Element Biosciences SeraCare BaseClear Ginkgo Bioworks, Inc. Strand Life Sciences BlueBee Evozyne NantHealth nextsequence Xcelris Labs Ltd. ELIOGEN GENOOX Knome Inc. Illumina, Coriell Institute for Medical Research NantWorks GeneDx Bioinformatics Solutions Inc. biobase One Codex Genomics England Mendelian NanoString Technologies, Inc. Precision Genomics, A Ludwig Enterprises Co. Alnylam Pharmaceuticals #genomics #ngs #genome #biotechnology

Metagenomic Sequencing Market Size to Hit USD 4.5 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/dh3xH77Q The global metagenomic sequencing market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $4.5 billion in 2028, growing at a CAGR of 17.5% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Azenta Life Sciences BGI Group DNASTAR Eurofins Scientific Finland Oy Illumina IntegraGen MEDGENOME Microsynth AG Novogene Oxford Nanopore Technologies PACIFIC BIOSCIENCES OF CALIFORNIA, INC. WHICH WILL DO BUSINESS IN CALIFORNIA AS PAC BIO, INC. PerkinElmer Psomagen QIAGEN Thermo Fisher Scientific Zymo Research Corp BaseClear B.V. Computomics CosmosID Intact Genomics, Inc. Metagenomi Terra Bioforge Veritas Genetics

Bioinformatics Market worth $18.7 billion by 2027 Download PDF Brochure @ https://lnkd.in/dZ-5eKDd The report "𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 & 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 (𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐓𝐨𝐨𝐥𝐬, 𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬, 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐒𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬), 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 (𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬, 𝐏𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬, 𝐓𝐫𝐚𝐧𝐬𝐜𝐫𝐢𝐩𝐭𝐨𝐦𝐢𝐜𝐬), & 𝐒𝐞𝐜𝐭𝐨𝐫𝐬 (𝐌𝐞𝐝𝐢𝐜𝐚𝐥, 𝐀𝐧𝐢𝐦𝐚𝐥) - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2027", was valued at USD 10.1 billion in 2022 and is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0%. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Thermo Fisher Scientific, Eurofins Scientific Finland Oy , QIAGEN, Agilent Technologies, Illumina, Waters Corporation , DNASTAR , NeoGenomics Laboratories , PerkinElmer, GeneWize, BGI Group, Fios Genomics, Partek, an Illumina company , SOPHiA GENETICS , Source BioScience, Biomax

DNA Sequencing with Nanopore Technology: Unlocking the Future of Genomics Request Sample PDF https://lnkd.in/gd46WcuX The global DNA sequencing market is experiencing rapid growth, driven by advances in genomics, personalized medicine, and biotechnology. 🌍💡 With applications ranging from drug development and diagnostics to agriculture and forensics, DNA sequencing is revolutionizing industries. The rise of next-generation sequencing (NGS) platforms has significantly reduced costs, making DNA analysis more accessible. This innovation is transforming how we approach disease treatment, enabling precision medicine and tailored therapies. 🎯 As the demand for genetic data continues to soar, the market is projected to reach new heights, presenting opportunities for innovation, partnerships, and investment. 🚀 #DNASequencing #Genomics #PrecisionMedicine #Biotech #HealthcareInnovation

Long Read Sequencing Market Size, Share & Trends Analysis Report By Type (Single-molecule Real Time Sequencing (#PacBio), #Nanopore Sequencing) By Application (#Diseases #Diagnosis, #Research, Others), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 The #longread #sequencing market is experiencing rapid growth due to advancements in genomic research and the increasing need for accurate and comprehensive #DNsequencintechnologies. Long-read sequencing (also known as third-generation sequencing) allows for the reading of longer DNA fragments, providing a more detailed and complete picture of genomes compared to short-read sequencing 📚 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:👇https://lnkd.in/dYb8Sq9b 📚 𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞:- 👇 MGITECH MicrobesNG Miroculus Nabsys Natera NGS Technologies 🇵🇰 Novogene America Nugen Technologies (Pty) Ltd Oxford Nanopore Technologies PacBio PACIFIC BIOSCIENCES OF CALIFORNIA, INC. WHICH WILL DO BUSINESS IN CALIFORNIA AS PAC BIO, INC. PerkinElmer QIAGEN QUANTUM BIOSYSTEMS USA, INC. RainDance Technologies Roche Saphetor SeqLL Inc. Sequenom Simplseq Inc Singlera Genomics Incorporated Stratos Genomics Takara Bio USA, Inc. Thermo Fisher Scientific Twist Bioscience Veracyte, Inc.

Metagenomic Sequencing Market Size to Hit USD 4.5 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/dh3xH77Q The global metagenomic sequencing market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $4.5 billion in 2028, growing at a CAGR of 17.5% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Azenta Life Sciences BGI Group DNASTAR Eurofins Scientific Finland Oy Illumina IntegraGen MEDGENOME Microsynth AG Novogene Oxford Nanopore Technologies PACIFIC BIOSCIENCES OF CALIFORNIA, INC. WHICH WILL DO BUSINESS IN CALIFORNIA AS PAC BIO, INC. PerkinElmer Psomagen QIAGEN Thermo Fisher Scientific Zymo Research Corp BaseClear B.V. Computomics CosmosID Intact Genomics, Inc. Metagenomi Terra Bioforge Veritas Genetics